Novartis announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, which overshadowed a modest outlook raise. Novartis CEO Vasant Narasimham speaks with Bloomberg's Scarlet Fu on the impact of pharma tariffs.

Stew Leonard Jr., Stew Leonard's President & CEO Talks Consumer Affordability Crunch
07:25

Micron CEO Sanjay Mehrotra Talks Expanding Chip Production, Memory Demand
10:22

Rob Kaplan, Goldman Sachs Vice Chairman & Former Dallas Fed President, Talks Kevin Warsh
06:43